Asieris and Lecheng Sinopharm Entered into a Strategic Cooperation Agreement

Shanghai, China, March 24, 2021 – Asieris Pharmaceuticals announced today that the company has entered into a strategic cooperation agreement with Lecheng Sinopharm.

Under the agreement, both companies will integrate resources to introduce and provide innovative drugs and medical devices projects of great potential to Boao Lecheng International Medical Tourism Pilot Zone (Boao Lecheng Pilot Zone), working together to promote project implementation and proactively participating in the pilot research center of Clinical Real World Data , making Boao Lecheng Pilot Zone the entry gateway of world-class innovative drugs and medical devices for China.